Log In
BCIQ
Print this Print this
 

ABBV-974, GLPG1837

  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionCystic fibrosis transmembrane conductance regulator (CFTR) potentiator
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation
PartnerAbbVie Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$405.0M

$45.0M

$360.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/30/2013

$405.0M

$45.0M

$360.0M

Get a free BioCentury trial today